Intimation of Appointment of Company Secretary & Compliance officer pursuant to Regulation 30 of sebi(LODR) Regulation 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals Ltd has appointed Ms. Palak Jain as the new Company Secretary & Compliance Officer of the company, effective May 6, 2025. The appointment was made by the Board based on the recommendation of the Nomination & Remuneration Committee. Ms. Jain is a qualified Company Secretary and B.Com graduate with knowledge of applicable corporate laws. The appointment is to fill the casual vacancy created by the resignation of the previous Company Secretary & Compliance Officer. She does not hold any shares in the company.
This is a routine compliance filing and ensures the company meets SEBI's regulatory requirement of having a Company Secretary & Compliance Officer in place. The underlying resignation of the previous CS is a minor governance signal but the quick replacement suggests continuity in compliance functions. No material impact expected on the stock price.